Sorry to seemingly spam the board guys, but to add on to my previous two posts (the edit time ran out). It is interesting to note that ACTC market cap never went below 150 million after fda approval for phase1/2 approval and fluctuated as high as 290 million (which would put as around 12-15 cent range). Again this is all my opinion, but I think that's probably a wise target range to sell after news.